173 related articles for article (PubMed ID: 8692530)
41. Differential response of serum alkaline phosphatase and serum osteocalcin in Paget's osteosarcoma.
Davie MW; Worsfold M; Sharp CA
Ann Clin Biochem; 1991 Mar; 28 ( Pt 2)():194-5. PubMed ID: 1859160
[TBL] [Abstract][Full Text] [Related]
42. Serum bone-specific alkaline phosphatase as a biomarker for osseous metastases in patients with malignant carcinomas: a systematic review and meta-analysis.
Du WX; Duan SF; Chen JJ; Huang JF; Yin LM; Tong PJ
J Cancer Res Ther; 2014 Nov; 10 Suppl():C140-3. PubMed ID: 25450272
[TBL] [Abstract][Full Text] [Related]
43. Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography.
Sharp CA; Linder C; Magnusson P
Clin Chim Acta; 2007 Apr; 379(1-2):105-12. PubMed ID: 17289010
[TBL] [Abstract][Full Text] [Related]
44. P-glycoprotein levels predict poor outcome in patients with osteosarcoma.
Hornicek FJ; Gebhardt MC; Wolfe MW; Kharrazi FD; Takeshita H; Parekh SG; Zurakowski D; Mankin HJ
Clin Orthop Relat Res; 2000 Apr; (373):11-7. PubMed ID: 10810457
[TBL] [Abstract][Full Text] [Related]
45. Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.
Bergman A; Qureshi AR; Haarhaus M; Lindholm B; Barany P; Heimburger O; Stenvinkel P; Anderstam B
J Nephrol; 2017 Apr; 30(2):255-262. PubMed ID: 26994005
[TBL] [Abstract][Full Text] [Related]
46. [Serum isoenzymes of lactate dehydrogenase, esterase and alkaline phosphatase in several bone tumors].
Surinov BP; Menzhinskaia GV
Vopr Onkol; 1975; 21(5):23-6. PubMed ID: 1108434
[No Abstract] [Full Text] [Related]
47. [A comparison of serum concentrations of biochemical bone turnover markers in patients with osteosarcoma with good and poor prognosis].
Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
Pol Merkur Lekarski; 2010 Jul; 29(169):19-26. PubMed ID: 20712242
[TBL] [Abstract][Full Text] [Related]
48. [Evaluation of selected cytokines in children and adolescents with osteosarcoma at diagnosis - preliminary report].
Markiewicz K; Zeman K; Kozar A; Gołebiowska-Wawrzyniak M
Med Wieku Rozwoj; 2011; 15(1):25-31. PubMed ID: 21786509
[TBL] [Abstract][Full Text] [Related]
49. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma.
Sternberg RA; Pondenis HC; Yang X; Mitchell MA; O'Brien RT; Garrett LD; Helferich WG; Hoffmann WE; Fan TM
J Vet Intern Med; 2013; 27(4):955-63. PubMed ID: 23734720
[TBL] [Abstract][Full Text] [Related]
50. Online assay of bone specific alkaline phosphatase with a flow injection-bead injection system.
Hartwell SK; Somprayoon D; Kongtawelert P; Ongchai S; Arppornchayanon O; Ganranoo L; Lapanantnoppakhun S; Grudpan K
Anal Chim Acta; 2007 Sep; 600(1-2):188-93. PubMed ID: 17903483
[TBL] [Abstract][Full Text] [Related]
51. Serum fluoride and sialic acid levels in osteosarcoma.
Sandhu R; Lal H; Kundu ZS; Kharb S
Biol Trace Elem Res; 2011 Dec; 144(1-3):1-5. PubMed ID: 19390788
[TBL] [Abstract][Full Text] [Related]
52. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
53. Pathology of osteosarcoma.
Dahlin DC
Clin Orthop Relat Res; 1975 Sep; (111):23-32. PubMed ID: 168999
[TBL] [Abstract][Full Text] [Related]
54. MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma.
Cao L; Wang J; Wang PQ
Biomed Pharmacother; 2016 Dec; 84():828-835. PubMed ID: 27723574
[TBL] [Abstract][Full Text] [Related]
55. Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.
Rodriguez-Galindo C; Poquette CA; Daw NC; Tan M; Meyer WH; Cleveland JL
Med Pediatr Oncol; 2001 Jun; 36(6):605-11. PubMed ID: 11344491
[TBL] [Abstract][Full Text] [Related]
56. Detection of Plasma MicroRNA Signature in Osteosarcoma Patients.
Allen-Rhoades W; Yustein JT
Methods Mol Biol; 2018; 1699():113-118. PubMed ID: 29086373
[TBL] [Abstract][Full Text] [Related]
57. The effect of growth hormone treatment on serum bone alkaline phosphatase in growth hormone deficient children.
Korpal-Szczyrska M; Balcerska A
Pediatr Endocrinol Diabetes Metab; 2008; 14(4):211-4. PubMed ID: 19239787
[TBL] [Abstract][Full Text] [Related]
58. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
59. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer.
Reale MG; Santini D; Marchei GG; Manna A; Del Nero A; Bianco V; Marchei P; Frati L
Int J Biol Markers; 1995; 10(1):42-6. PubMed ID: 7629426
[TBL] [Abstract][Full Text] [Related]
60. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
